HCV treatment reduces liver cancer mortality risks

We know that identifying and treating HCV early with 8-12 weeks of direct acting anti-viral (DAA) medication can prevent the development of hepatocellular carcinoma (HCC), a very dangerous form of liver cancer. But did you know that treatment can also reduce the risk of death in patients who already have a history of HCC? Researchers […]

Read more

World Hepatitis Day

July 28th, World Hepatitis Day, is a time to join together and raise awareness about the the global burden of viral hepatitis.  Visit WorldHepatitisDay to learn how you can get involved.     View the World Hepatitis Alliance’s video on finding the millions of people who have hepatitis and don’t know it:    

Read more

A new model of HCV treatment access

Although the new drugs to treat HCV are very effective (at least 9 out of 10 people can be cured in 8-12 weeks), they are very expensive, especially for people who do not have insurance. Even for patients with insurance, co-pay costs may make treatment unaffordable. Prices are so high that state-funded programs like Medicaid […]

Read more

Hepatitis C screening saves lives

HCV is the most common blood-borne infection in the US and a leading cause of liver failure and liver cancer. But most people who have it do not know they are infected. The good news is that HCV can be cured, often in just three months with daily medication.  Pharmaceutical assistance pathways offer free or […]

Read more

Welcome to our new site!

We are happy to announce the launch of our new site to empower the public and the health care workforce in screening, managing, and treating HCV. It is estimated that 3 to 5 million people in the US have HCV. Nearly half of these people don’t know they are infected. 75% of the infected population […]

Read more